Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Vicky Gregg Biography and Net Worth

Director of Quest Diagnostics

Vicky B. Gregg serves as Independent Director of the Company. Ms. Gregg is a partner with Guidon Partners LLC. She retired as Chief Executive Officer of Blue Cross Blue Shield of Tennessee in 2012. Prior to becoming CEO in 2003, Ms. Gregg served in a number of other leadership roles, including President and Chief Operating Officer. Before that, she held a series of senior roles at Humana Health Plans. Ms. Gregg served as a member of the U.S. National Institutes of Health Commission on Systemic Interoperability. She currently serves on the boards of Acadia Healthcare Company, Inc. and the Electric Power Board of Chattanooga, as well as the boards of several private companies. Previously, Ms. Gregg served on several national boards, including TeamHealth Holdings, Inc. from 2013 to 2017 and First Horizon National Corporation from 2011 to 2015. She has also served as Chair of America’s Health Insurance Plans, as a member of the BlueCross BlueShield Association, as Chair of the Board of the National Institute for Healthcare Management, and as a member of the Healthcare Leadership Council.

What is Vicky B. Gregg's net worth?: The estimated net worth of Vicky B. Gregg is at least $2.50 million as of February 23rd, 2024. Ms. Gregg owns 16,329 shares of Quest Diagnostics stock worth more than $2,499,970 as of December 21st. This net worth estimate does not reflect any other assets that Ms. Gregg may own. Learn More about Vicky B. Gregg's net worth.
How do I contact Vicky B. Gregg?: The corporate mailing address for Ms. Gregg and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on Vicky B. Gregg's contact information.
Has Vicky B. Gregg been buying or selling shares of Quest Diagnostics?: Vicky B. Gregg has not been actively trading shares of Quest Diagnostics in the last ninety days. Most recently, Vicky B. Gregg sold 2,500 shares of the business's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $126.64, for a transaction totalling $316,600.00. Following the completion of the sale, the director now directly owns 16,329 shares of the company's stock, valued at $2,067,904.56. Learn More on Vicky B. Gregg's trading history.
Who are Quest Diagnostics' active insiders?: Quest Diagnostics' insider roster includes Mark Delaney (SVP), Michael Deppe (CAO), Catherine Doherty (SVP), Vicky Gregg (Director), Mark Guinan (CFO), Karthik Kuppusamy (SVP), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.
Are insiders buying or selling shares of Quest Diagnostics?: In the last twelve months, insiders at the medical research company sold shares 10 times. They sold a total of 39,850 shares worth more than $5,692,423.40. The most recent insider tranaction occured on November, 6th when CAO Michael J Deppe sold 18,755 shares worth more than $2,889,207.75. Insiders at Quest Diagnostics own 0.8% of the company. Learn More about insider trades at Quest Diagnostics.
Information on this page was last updated on 11/6/2024.

Vicky B. Gregg Insider Trading History at Quest Diagnostics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/23/2024	Sell	2,500	$126.64	$316,600.00	16,329

Vicky B. Gregg Buying and Selling Activity at Quest Diagnostics

Quest Diagnostics Company Overview

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Today's Range

Now: $153.10

$151.68

$154.10

50 Day Range

MA: $157.03

$147.40

$164.19

2 Week Range

Now: $153.10

$123.04

$165.32

Volume

1,344,317 shs

Average Volume

917,121 shs

Market Capitalization

$17.09 billion

P/E Ratio

20.58

Dividend Yield

1.98%

Beta

0.89